Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 287, Issue 1 50-1, 2004, Pages

  Sahai, Atul ^a,b   Malladi, Padmini ^a   Melin Aldana, Hector ^a   Green, Richard M ^a   Whitington, Peter F ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Fatty liver; Fibrosis; Inflammation; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLINE; COLLAGEN TYPE 1; MESSENGER RNA; METHIONINE; OSTEOPONTIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET; DIETARY INTAKE; FEMALE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; INFLAMMATION; LIVER CELL CULTURE; LIVER FIBROSIS; LIVER INJURY; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH1 CELL; UPREGULATION;

ALANINE TRANSAMINASE; ANIMALS; CHOLINE DEFICIENCY; COLLAGEN TYPE I; DIET; FATTY LIVER; FEMALE; HEPATOCYTES; LIVER; LIVER CIRRHOSIS; METHIONINE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MOLECULAR WEIGHT; ORGAN SIZE; OSTEOPONTIN; OXIDATIVE STRESS; SIALOGLYCOPROTEINS; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 3042550624     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00002.2004     Document Type: Article

References (49)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231, 2002.
2. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, Rittling SR, Denhardt DT, Glimcher MJ, and Cantor H. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287: 860-864, 2000.
3. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21: 3-16, 2001.
4. Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, Sobel RA, Lock C, Karpuj M, Pedotti R, Heller R, Oksenberg JR, and Steinman L. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294: 1731-1735, 2001.
5. Chiba S, Okamoto H, Kon S, Kimura C, Murakami M, Inobe M, Matsui Y, Sugawara T, Shimizu T, Uede T, and Kitabatake A. Development of atherosclerosis in osteopontin transgenic mice. Heart Vessels 16: 111-117, 2002.
6. Crespo J, Cayon A, Fernandez-Gil P, Hernandez-Guerra M, Mayorga M, Dominguez-Diez A, Fernandez-Escalante JC, and Pons-Romero F. Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75 in nonalcoholic steatohepatitis patients. Hepatology 34: 1158-1163, 2001.
7. Denhardt DT, Giachelli CM, and Rittling SR. Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol 41: 723-749, 2001.
8. Denhardt DT, Noda M, O'Regan AW, Pavlin D, and Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 107: 1055-1061, 2001.
9. Diehl AM. Nonalcoholic Steatosis and Steatohepatitis. IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am J Physiol Gastrointest Liver Physiol 282: G1-G5, 2002.
10. Fischer JW, Tschope C, Reinecke A, Giachelli CM, and Unger T. Upregulation of osteopontin expression in renal cortex of streptozotocin-induced diabetic rats is mediated by bradykinin. Diabetes 47: 1512-1518, 1998.
11. Friedman SL. Cytokines and fibrogenesis. Semin Liver Dis 19: 129-140, 1999.
12. Giachelli CM, Pichler R, Lombardi D, Denhardt DT, Alpers CE, Schwartz SM, and Johnson RJ. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 45: 515-524, 1994.
13. Gotoh M, Sakamoto M, Kanetaka K, Chuuma M, and Hirohashi S. Overexpression of osteopontin in hepatocellular carcinoma. Pathol Int 52: 19-24, 2002.
14. Hellerbrand C, Stefanovic B, Giordano F, Burchardt ER, and Brenner DA. The role of TGF-β1 in initiating hepatic stellate cell activation in vivo. J Hepatol 30: 77-87, 1999.
15. Isoda K, Nishikawa K, Kamezawa Y, Yoshida M, Kusuhara M, Moroi M, Tada N, and Ohsuzu F. Osteopontin plays an important role in the development of medial thickening and neointimal formation. Circ Res 91: 77-82, 2002.
16. Kawashima R, Mochida S, Matsui A, YouLuTu ZY, Ishikawa K, Toshima K, Yamanobe F, Inao M, Ikeda H, Ohno A, Nagoshi S, Uede T, and Fujiwara K. Expression of osteopontin in Kupffer cells and hepatic macrophages and Stellate cells in rat liver after carbon tetrachloride intoxication: a possible factor for macrophage migration into hepatic necrotic areas. Biochem Biophys Res Commun 256: 527-531, 1999.
17. Koniaris LG, Zimmers-Koniaris T, Hsiao EC, Chavin K, Sitzmann JV, and Farber JM. Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J Immunol 167: 399-406, 2001.
18. Kugelmas M, Hill DB, Vivian B, marsano L, and McClain CJ. Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E. Hepatology 38: 413-419, 2003.
19. Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, and Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 105: 1067-1075, 2000.
20. Leclercq IA, Farrell GC, Schriemer R, and Robertson GR. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol 37: 206-213, 2002.
21. Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, deSimone C, Song X, and Diehl AM. Probiotics and antibodies to TNF-α inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37: 343-350, 2003.
22. Liaw L, Lombardi DM, Almeida MM, Schwartz SM, deBlois D, and Giachelli CM. Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. Arterioscler Thromb Vasc Biol 17: 188-193, 1997.
23. Lin YH, Huang CJ, Chao JR, Chen ST, Lee SF, Yen JJ, and Yang-Yen HF. Coupling of osteopontin and its cell surface receptor CD44 to the cell survival response elicited by interleukin-3 or granulocyte-macrophage colony-stimulating factor. Mol Cell Biol 20: 2734-2742, 2000.
24. Malyankar UM, Scatena M, Suchland KL, Yun TJ, Clark EA, and Giachelli CM. Osteoprotegerin is an αvβ3-induced, NF-κB-dependent survival factor for endothelial cells. J Biol Chem 275: 20959-20962, 2000.
25. Martinez-Chantar ML, Corrales FJ, Martinez-Cruz LA, Garcia-Trevijano ER, Huang ZZ, Chen L, Kanel G, Avila MA, Mato JM, and Lu SC. Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase IA. FASEB J 16: 1292-1294, 2002.
26. Martinez-Chantar ML, Garcia-Trevijano ER, Latasa MU, Perez-Mato I, Sanchez del Pino MM, Corrales FJ, Avila MA, and Mato JM. Importance of a deficiency in S-adenosyl-L-methionine synthesis in the pathogenesis of liver injury. Am J Clin Nutr 76: 1177S-1182S, 2002.
27. Mazzali M, Jefferson JA, Ni Z, Vaziri ND, and Johnson RJ. Microvascular and tubulointerstitial injury associated with chronic hypoxia-induced hypertension. Kidney Int 63: 2088-2093, 2003.
28. Mazzali M, Kipari T, Ophascharoensuk V, Wesson JA, Johnson R, and Hughes J. Osteopontin-a molecule for all seasons. QJM 95: 3-13, 2002.
29. Nambi P, Gellai M, Wu HL, and Prabhakar U. Upregulation of osteopontin in ischemia-induced renal failure in rats: a role for ET-1. Biochem Biophys Res Commun 241: 212-214, 1997.
30. Ohkawa H, Ohishi N, and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358, 1979.
31. Ophascharoensuk V, Giachelli CM, Gordon K, Hughes J, Pichler R, Brown P, Liaw L, Schmidt R, Shankland SJ, Alpers CE, Couser WG, and Johnson RJ. Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56: 571-580, 1999.
32. O'Regan A and Berman JS. Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int J Exp Pathol 81: 373-390, 2000.
33. O'Regan AW, Chupp GL, Lowry JA, Goetschkes M, Mulligan N, and Berman JS. Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. J Immunol 162: 1024-1031, 1999.
34. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, David E, Cavallo-Perin P, and Rizzetto M. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 35: 367-372, 2002.
35. Persy VP, Verhulst A, Ysebaert DK, De Greef KE, and De Broe ME. Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice. Kidney Int 63: 543-553, 2003.
36. Pichler R, Giachelli CM, Lombardi D, Pippin J, Gordon K, Alpers CE, Schwartz SM, and Johnson RJ. Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin). Am J Pathol 144: 915-926, 1994.
37. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 121: 710-723, 2001.
38. Robertson G, Leclercq I, and Farrell GC. Nonalcoholic Steatosis and Steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol 281: G1135-G1139, 2001.
39. Rozental P, Biava C, Spencer H, and Zimmerman HJ. Liver morphology and function tests in obesity and during total starvation. Am J Dig Dis 12: 198-208, 1967.
40. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, and Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120: 1183-92, 2001.
41. Sodhi CP, Batlle D, and Sahai A. Osteopontin mediates hypoxia-induced proliferaion of cultured mesangial cells: Role of PKC and p38 MAPK. Kidney Int 58: 691-700, 2000.
42. Sodhi CP, Phadke SA, Batlle D, and Sahai A. Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis: role of osteopontin. Am J Physiol Renal Physiol 280: F667-F674, 2001.
43. Sodhi CP, Phadke SA, Batlle D, and Sahai A. Hypoxia stimulates osteopontin expression and proliferation of cultured vascular smooth muscle cells: potentiation by high glucose. Diabetes 50: 1482-1490, 2001.
44. Takemoto M, Yokote K, Nishimura M, Shigematsu T, Hasegawa T, Kon S, Uede T, Matsumoto T, Saito Y, and Mori S. Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis. Arterioscler Thromb Vasc Biol 20: 624-628, 2000.
45. Towler DA, Bidder M, Latifi T, Coleman T, and Semenkovich CF. Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J Biol Chem 273: 30427-30434, 1998.
46. Valenzuela A, Fernandez V, and Videla LA. Hepatic and biliary levels of glutathione and lipid peroxides following iron overload in the rat: effect of simultaneous ethanol administration. Toxicol Appl Pharmacol 70: 87-95, 1983.
47. Weltman MD, Farrell GC, and Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 111: 1645-1653, 1996.
48. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, and Cummins AG. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 48: 206-211, 2001.
49. Ye QH, Qin LX, Forgues M, He P, Kim JW, Peng AC, Simon R, Li Y, Robles AI, Chen Y, Ma ZC, Wu ZQ, Ye SL, Liu YK, Tang ZY, and Wang XW. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 9: 416-423, 2003.